Competitive problems in the drug industry: hearings before Subcommittee on Monopoly and Anticompetitive Activities of the Select Committee on Small Business, United States Senate, Ninety-first Congress, first session ... |
From inside the book
Results 1-5 of 77
Page 16557
... testimony specifically on the safety , efficacy and usefulness of propoxyphene , an analgesic widely sold under the trade name Darvon . Testimony by medical experts in 1970 before this committee held that Darvon , on which Americans ...
... testimony specifically on the safety , efficacy and usefulness of propoxyphene , an analgesic widely sold under the trade name Darvon . Testimony by medical experts in 1970 before this committee held that Darvon , on which Americans ...
Page 16561
... to present it however you desire . 1 Drug Industry Antitrust Act , hearings on S. 1552 , pp . 320-321 . Testimony of Dr. Walter Modell . STATEMENT OF SIDNEY M. WOLFE , M.D. , PUBLIC CITIZEN'S COMPETITIVE PROBLEMS IN THE DRUG INDUSTRY 16561.
... to present it however you desire . 1 Drug Industry Antitrust Act , hearings on S. 1552 , pp . 320-321 . Testimony of Dr. Walter Modell . STATEMENT OF SIDNEY M. WOLFE , M.D. , PUBLIC CITIZEN'S COMPETITIVE PROBLEMS IN THE DRUG INDUSTRY 16561.
Page 16608
... testimony when you get the record back . One further followup question on the point raised by Senator Haya- kawa . The marketing of drugs is based upon a very specific statute , which says you must prove efficacy and safety by well ...
... testimony when you get the record back . One further followup question on the point raised by Senator Haya- kawa . The marketing of drugs is based upon a very specific statute , which says you must prove efficacy and safety by well ...
Page 16609
... testimony , that they point out that barbiturates , at least several of them , have a higher rate of deaths per million prescriptions . An earlier report they put out in 1976 , at least looked at one bar- biturate , and they looked at ...
... testimony , that they point out that barbiturates , at least several of them , have a higher rate of deaths per million prescriptions . An earlier report they put out in 1976 , at least looked at one bar- biturate , and they looked at ...
Page 16610
... testimony . Senator NELSON . I am puzzled about this 26 - month period . Was that a selection of that period by you , or was that the study period done by Justice ? Dr. WOLFE . You are talking about page 6 of the petition to the Justice ...
... testimony . Senator NELSON . I am puzzled about this 26 - month period . Was that a selection of that period by you , or was that the study period done by Justice ? Dr. WOLFE . You are talking about page 6 of the petition to the Justice ...
Other editions - View all
Common terms and phrases
acetaminophen addition Administration alcohol American analgesia analgesic analgesic effect aspirin associated barbiturates BEAVER blood clinical codeine combination Commissioner KENNEDY Committee compound Controlled Substances Act Darvon DAWN data dextropropoxyphene diazepam doctor doses of propoxyphene double-blind drug abuse Drug Enforcement Drug Enforcement Administration efficacy Eli Lilly emergency room evaluation factors fatalities Finkle Forensic Sciences Forensic Toxicology FURMAN Health heroin Hospital indicates investigation Journal McBay medical examiner Medicine metabolite mild analgesics milligrams Moertel morphine narcotic norpropoxyphene oral overdose oxycodone pain relief patients pentazocine percent Pharmacology phenacetin phene physicians placebo effect placebo reaction placebo response poxyphene prescribed prescription problem propoxy propoxyphene propoxyphene deaths propoxyphene hydrochloride propoxyphene napsylate propoxyphene products propoxyphene-related deaths Psychiatry psychological psychotherapy reported Research Rickels Rosenthal Schedule Schedule II Senator LEVIN Senator NELSON Shapiro side effects significant smoking Strupp studies suicide tablets testimony therapeutic therapist therapy tion toxicity treatment Wolfe